54 Peer-reviewed published journal articles (excluding published abstracts, oral presentations and conference proceedings) + 04 peer-reviewed textbook chapters + 03 Theses

ORCID ID: orcid.org/0000-0003-0795-394X

Scopus Author ID: 55649436300

Google Scholar Profile: (h-index = 25, i10-index = 41)

ResearchGate Profile: https://www.researchgate.net/profile/Fidele_Ntie-Kang

RG Score = 43.25, which is higher than the RG Scores of 97.5% of all researchers on ResearchGate)

Web of Science (WoS): Researcher ID = B-5877-2013

 

*Corresponding author

†Joint first author

 

Peer-reviewed journal articles

 

  1. Sharma, P.; Shri, R.; Ntie-Kang, F.;* Kumar, S.* Phytochemical and ethnopharmacological perspectives of Ehretia laevis. Molecules, 2021,  (submitted).
  2. Ntie-Kang, F.;* Telukunta, K. K.; Fobofou, S. A. T.; Osamor, V. C.; Egieyeh, S. A.; Valli, M.; ...; Ludwig-Müller, J.* Computational Applications in Secondary Metabolite Discovery (CAiSMD): An online workshop. Journal of Cheminformatics, 2021, (submitted).
  3. Ibezim A.; Ibezim, A.; Ntie-Kang, F.; Nwodo, N. J.; Onuku, R. S.; Adikwu, M. U. Structure-based virtual screening and molecular dynamic simulation studies to discover new COVID-19 main protease inhibitors. Scientific African, 2021, (submitted).
  4. Kumar, D.; Sharma, P.; Shabu, S.; Kaur, R.; Lobe, M. M. M.; Gupta, G. K.; Ntie-Kang, F.* In search of therapeutic candidates for HIV/AIDS: Rational approaches, design strategies, structure-activity relationship and mechanistic insights. RSC Advances, 2021, DOI: 10.1039/d0ra10655k.
  5. Ekaney, L. Y. E.; Eni, D. B.; Ntie-Kang, F.* Chemical similarity methods for analysing secondary metabolite structures. Physical Sciences Reviews, 2021, DOI: 10.1515/psr-2018-0129.
  6. Ngo Hanna, J.; Nziko, V. P. N.; Ntie-Kang, F.;* Mbah, J. A.; Toze, F. A. A. The use of minimal topological differences to inspire the design of novel tetrahydroisoquinoline analogs with anti-malarial activity. Heliyon, 2021, (accepted).
  7. Paul, L.; Shadrack, D. M.; Mudogo, C. N.; Mtei, K. M.; Machunda, R. L.; Ntie-Kang, F.* Structural characterization of cassava linamarase-linamarin enzyme complex: an integrated computational approach. Journal of Biomolecular Structure and Dynamics, 2021, DOI: 10.1080/07391102.2021.1925156.
  8. Babiaka, S. B.;* Moumbock, A. F. A.; Günther, S.; Ntie-Kang, F.* Natural products in Cyperus rotundus L. (Cyperaceae): an update of the chemistry and pharmacological activities. RSC Advances, 2021, 11, 15060-15077.
  9. Sippl, W.; Ntie-Kang, F.* Editorial to Special Issue—“Structure-Activity Relationships (SAR) of Natural Products”. Molecules, 2021, 26, 250.
  10. Ngo Hanna, J.; Bekono, B. D.; Owono, L. C. O.; Toze, F. A. A.; Mbah, J. A.; Güther, S.; Ntie-Kang, F.* A chemoinformatic analysis of atoms, scaffolds and functional groups in natural products. Physical Sciences Reviews, 2021, DOI: 10.1515/psr-2019-0096.
  11. Bekono, B. D.; Sona, A. N.; Eni, D. B.; Owono, L. C. O.; Megnasan, E.; Ntie-Kang, F.* Molecular mechanics approaches for rational drug design: forcefields and solvation models. Physical Sciences Reviews, 2021, DOI: 10.1515/psr-2019-0128.
  12. Moumbock, A. F. A.; Gao, M.; Qaseem, A.; Li, J.; Kirchner, P. A.; Ndingkokhar, B.; Bekono, B. D.; Simoben, C. V.; Babiaka, B. D., Malange, Y. I.; Sauter, F.; Zierep, P.; Ntie-Kang, F.; Günther, S. StreptomeDB 3.0: an updated compendium of streptomycetes natural products. Nucleic Acids Research, 2021, 19, D600–D604.
  13. Ntie-Kang, F.;* Mayack, B. K.; Valente, S.; Battistelli, C.* Editorial: Natural product epigenetic modulators and inhibitors. Frontiers in Pharmacology, 2021, 12, 95.
  14. Babiaka, S. B.;* Simoben, C. V.; Abuga, K. O.; Mbah, J. A.; Karpoormath, R.; Ongarora, D.; Mugo, H.; Monya, E.; Cho-Ngwa, F.; Sippl, W.; Loveridge, E. J.; Ntie-Kang, F.* Alkaloids with anti-onchocercal activity from Voacanga africana Stapf (Apocynaceae): Identification and molecular modeling. Molecules, 2021, 26, 70.
  15. Kamdem, R. S. T.; Ogbole, O.; Wafo, P.; Uzor, P.; Ali, Z.; Ntie-Kang, F.; Ikhlas A. Khan, I. A.; Spiteller, P. Rational engineering of specialized metabolites in bacteria and fungi. Physical Sciences Reviews, 2021, DOI: 10.1515/psr-2018-0170. 
  16. Paul, L.;* Mudogo, C. N.; Mtei, K. M.; Machunda, R. L.; Ntie-Kang, F.* A computer-based approach for developing linamarase inhibitory agents. Physical Sciences Reviews, 2020, DOI: 10.1515/psr-2020-0098.
  17. Simoben, C. V.;* Qaseem, A.; Moumbock, A. F. A.; Telukunta, K. K.; Günther, S.; Sippl, W.; Ntie-Kang, F.* Pharmacoinformatic investigation of medicinal plants from East Africa. Molecular Informatics, 2020, 39, e2000163. 
  18. Kaur, R.; Sharma, P.; Gupta, G. K.; Ntie-Kang, F.;*Kumar, D.* Structure-activity-relationship and mechanistic insights for anti-HIV natural products. Molecules, 2020, 25, 2070.
  19. Akone, S. H.; Ntie-Kang, F.; Stuhldreier, F.; Ewonkem, M. B.; Noah, A. M.; Mouelle, S. E. M.; Müller, R. Natural products impacting DNA methyltransferases and histone deacetylases. Frontiers in Pharmacology, 2020, 11, 992.
  20. Karaman Mayack, B.; Sippl, W.; Ntie-Kang, F. Natural products as modulators of sirtuins. Molecules, 2020, 25, 3287.
  21. Duncan, M. C.; Onguéné, P. A.; Kihara, I.; Nebangwa, D. N.; Naidu, M. E.; Williams, D. E.; Balgi, A. D.; Andrae-Marobela, K.; Roberge, M.; Andersen, R. J.; Niikura, M.; Ntie-Kang, F.;* Tietjen I.* Virtual screening identifies chebulagic acid as an Inhibitor of the M2(S31N) viral ion channel and influenza A virus. Molecules, 2020, 25, 2903.
  22. Divsalar D. N.; Simoben C. V.; Schonhofer, C.; Richard, K.; Sippl, W.; Ntie-Kang, F.;* Tietjen I.* Novel histone deacetylase inhibitors and HIV-1 latency-reversing agents identified by large-scale virtual screening. Frontiers in Pharmacology, 2020, 11, 905.
  23. Babiaka, S. B.;* Nia, R.; Abuga, K. O.; Mbah, J. A.; Nziko, V. P. N.; Paper, D. H.; Ntie-Kang, F.* Antioxidant potential of flavonoid glycosides from Manniophyton fulvum (Euphorbiaceae): Identification and molecular modeling. Scientific African, 2020 , 8, e00423.
  24. Bekono, B. D. ;† Ntie-Kang, F.;*† Onguéné, P. A; Lifongo, L. L.; Sippl, W.; Fester, K.; Owono, L. C. O.* The potential of anti‑malarial compounds derived from African medicinal plants: a review of pharmacological evaluations from 2013 to 2019. Malaria Journal, 2020, 19, 183.
  25. Simoben, C. V.; Ntie-Kang, F.; Robaa, D.; Sippl, W. Case studies on computer-based identification of natural products as lead molecules. Physical Sciences Reviews. 2020; DOI: 10.1515/psr-2019-0119.
  26. Asogwa, F. C.; Ibezim, A.; Ntie-Kang, F.; Asogwa, C. J.; Okoye, C. O. B. Anti-psoriatic and immunomodulatory evaluation of Psorospermum febrifugum Spach and its phytochemicals. Scientific African, 2020, 7, e00229.
  27. Ntie-Kang, F.;* Svozil, D. An enumeration of natural products from microbial, marine and terrestrial sources. Physical Sciences Reviews, 2019; DOI: 10.1515/psr-2018-0121.
  28. Kaur, T.; Sharma, P.; Gupta, G. K.; Ntie-Kang, F.; Kumar, D. Treatment of tuberculosis by natural drugs : a review. Plant Archives, 2019, 19, 2168-2176.
  29. Ntie-Kang, F. Chemoinformatics at the service of natural product drug discovery. Physical Sciences Reviews, 2019, DOI: 10.1515/psr-2018-0102.
  30. Moumbock, A. F. A.; Ntie-Kang, F.; Akone, H. S.; Li, J.; Gao, M.; Telukunta, K. K., Günther S. An overview of tools, software and methods for natural product fragment and mass spectral analysis. Physical Sciences Reviews, 2019, DOI: 10.1515/psr-2018-0126.
  31. Ntie-Kang, F.* Mechanistic role of plant-based bitter principles and bitterness prediction for natural product studies I: Database and methods. Physical Sciences Reviews, 2019, DOI: 10.1515/psr-2018-0117.
  32. Ntie-Kang, F.* Mechanistic role of plant-based bitter principles and bitterness prediction for natural product studies II: prediction tools and case studies. Physical Sciences Reviews, 2019, 10.1515/psr-2019-0007.
  33. Ntie-Kang, F.;* Nyongbela, K. D.; Ayimele, G. A.; Shekfeh, S. “Drug-likeness” properties of natural compounds. Physical Sciences Reviews, 2019, DOI: 0.1515/psr-2018-0169.
  34. Najjar, A.; Olğaç, A.; Ntie-Kang, F.; Sippl, W. Fragment-based drug design of nature-inspired compounds. Physical Sciences Reviews, 2019, DOI: 10.1515/psr-2018-0110.
  35. Athar, M.; Sona, A. N.: Bekono, B. D.; Ntie-Kang, F.* Fundamental physical and chemical concepts behind “druglikeness” and “natural product-likeness”. Physical Sciences Reviews, 2019, DOI: 10.1515/psr-2018-0101.
  36. Koulouridi, E.; Valli, M.; Ntie-Kang, F.; Bolzani, V. S. A primer on natural product-based virtual screening. Physical Sciences Reviews, 2018, DOI: 10.1515/psr-2018-0105.
  37. Bankeu, J. J. K.; Sattar, H.; Fongang, Y. S. F.; Muhammadi, S. W.; Simoben, C. V.; Ntie-Kang, F.;* Feuya, G. R. T.; Tchuenmogne, M. A. T.; Lateef, M.; Lenta, B. N.; Ali, M. S.; Ngouela, A. S. Synthesis, urease inhibition and molecular modelling studies of novel derivatives of the naturally occurring β-amyrenone. Natural Products and Bioprospecting, 2018. DOI: 10.1007/s13659-018-0193-7
  38. Akone, H. S.; Cong-Dat P.; Chen, H.; Ola, A. R. B.; Ntie-Kang, F.; Proksch, P. Epigenetic modification, co-culture and genomic methods for natural product discovery. Physical Sciences Reviews, 2018, in press.
  39. Koulouridi, E.; Valli, M.; Ntie-Kang, F.; Bolzani, V. S. A primer on natural product-based virtual screening. Physical Sciences Reviews, 2018, accepted.
  40. Andersen, R.; Ntie-Kang, F.; Tietjen, I. Natural product-derived compounds in HIV suppression, remission, and eradication strategies. Antiviral Research, 2018,  158, 63-77.
  41. Ngemenya, M. N.; Abwenzoh, N. G.; Ikome, H. N.; Zofou, D.; Ntie-Kang, F.; Efange, S. M. N. Structurally simple synthetic piperidines with high selectivity for resistant Plasmodium falciparum. BMC Pharmacology and Toxicology, 2018, 19, 42.
  42. Kumar, D.; Sharma, P.; Nepali, K.; Mahajan, G.; Mintoo, M. J.; Singh, A.; Mondhe, D. M.; Singh, G.; Jain, S. K.; Gupta G. K.; Ntie-Kang F.* Antitumour, acute toxicity and molecular modeling studies of 4-(pyridin-4-yl)-6-(thiophen-2-yl)pyrimidin-2(1H)-one against ehrlich ascites carcinoma and sarcoma-180. Heliyon, 2018, 4, e00661.
  43. Simoben, C. V.; Ntie-Kang, F.;* Akone, S. H.; Sippl, W. Compounds from African medicinal plants with activities against parasitic diseases: schistosomiasis, trypanosomiasis and leishmaniasis. Natural Products and Bioprospecting, 2018, 8, 151-169.
  44. Karaman, B.;† Alhalabi, Z.;† Swyter, S.; Mihigo, S. O.; Andrae-Marobela, K.; Jung, M.; Sippl, W, Ntie-Kang, F.* Identification of bischalcones as sirtuin inhibitors by virtual screening and in vitro testing. Molecules, 2018, 23, 416.
  45. Onguéné, P. A;†  Simoben, C. V.;† Fotso, G. W.; Andrae-Marobela, K.; Khalid, S. A.; Ngadjui, B. T.; Mbaze, L. M.;  Ntie-Kang, F.*   In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV properties. Computational Biology and Chemistry, 2018, 72, 136–149.
  46. Kumar, D.; Sharma, P.; Singh, H.; Nepali, K.; Gupta, G. K.; Jain, S. K.; Ntie-Kang, F.*  The value of pyrans as anticancer scaffolds in medicinal chemistry. RSC Advances, 2017, 7, 36977-36999. 
  47. Ntie-Kang, F.;*†  Telukunta, K. K.;† Döring, K.;   Simoben, C. V.;  Moumbock, A. F. A.; Malange, Y. I.; Njume, L. E.; Yong, J. E.; Sippl, W.; Günther, S.  NANPDB: a resource for natural products from Northern African sources. Journal of Natural Products, 2017, 80, 2067-2076.
  48. Nyongbela, K. N.; Ntie-Kang, F.; Hoye, T. R.; Efange, S. M. N.  Antiparasitic sesquiterpenes from the Cameroonian spice Scleria striatinux and preliminary in vitro and in silico DMPK assessment. Natural Products and Bioprospecting, 2017, 7, 235-247.
  49. Ibezim, A.; Debnath, B.; Ntie-Kang, F.;* Mbah, C. J.; Nwodo, N. J. Binding of anti-Trypanosoma natural products from African flora against selected drug targets: A docking study. Medicinal Chemistry Research, 2017, 26, 562-579.
  50. Bekono, B. D.;†Ntie-Kang, F.;*†Owono, L. C. O.; Megnassan. E. Targeting cysteine proteases from Plasmodium falciparum: a general overview, rational drug design and computational approaches for drug discovery. Current Drug Targets, 2017, doi: 10.2174/1389450117666161221122432
  51. Ikome, H. N.;   Ntie-Kang, F.;*  Ngemenya, M. N.; Tu, Z.; Mash, R. H.;  Efange, S. M. N.  4-Aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: Synthesis, preliminary pharmacological evaluation and computational studies. Chemistry Central Journal, 2016, 10, 53.
  52. Ntie-Kang, F.;*†Simoben, C. V.;† Karaman, B.; Ngwa, V. F.; Judson, P. N.; Sippl, W.; Mbaze, L. M. Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants. Drug Design, Development and Therapy, 2016, 10, 2137-2154.
  53. Ntie-Kang, F.;* Njume E. L.; Malange, Y. I.; Günther, S.; Sippl, W.; Yong, J. N. The chemistry and biological activities of natural products from Northern African plant families: From Taccaceae to Zygophyllaceae. Natural Products and Bioprospecting, 2016, 6, 63-96.
  54. Nwodo, J. N.; Ibezim, A.; Simoben, C. V.; Ntie-Kang, F.* Exploring cancer therapeutics with natural products from African medicinal plants, part II: alkaloids, terpenoids and flavonoids. Anti-Cancer Agents in Medicinal Chemistry, 2016, 16, 108-127.
  55. Ibezim, A.; Onyia, K.; Ntie-Kang, F.; Nwodo, J. N. Drug-like properties of potential anti-cancer compounds from Cameroonian flora: A virtual study. Journal of Applied Pharmaceutical Science, 2015, 5, 133-137.
  56. Babiaka, S. B.;†Ntie-Kang, F.;*†Ndingkokhar, B.; Mbah, J. A.; Sippl, W.; Yong, J. N. The Chemistry and bioactivity of Southern African flora II: Flavonoids, quinones and minor compound classes. RSC Advances, 2015, 5, 57704-57720.
  57. Nwodo, J. N.; Ibezim, A.; Ntie-Kang, F.; Adikwu, M. U.; Mbah, C. J. Anti-trypanosomal activity of Nigerian plants and their constituents. Molecules, 2015, 20, 7750-7771.
  58. Babiaka, S. B.;†Ntie-Kang, F.;*†Lifongo, L. L.; Ndingkokhar, B.; Mbah, J. A.; Yong, J. N. The Chemistry and bioactivity of Southern African flora I: A bioactivity versus ethnobotanical survey of alkaloid and terpenoid classes. RSC Advances, 2015, 5, 43242-43267.
  59. Owono, L. C. O.; Ntie-Kang, F.; Keita, M.; Megnassan, E.; Frecer, V.; Miertus, S. Virtually designed triclosan-based inhibitors of enoyl-acyl carrier protein reductase of Mycobacterium tuberculosis and of Plasmodium falciparum. Molecular Informatics, 2015, 34, 292-307.
  60. Malolo, F. A. E.; Nouga, A. B.; Kakam, A.; Franke, K.; Ngah, L.; Flausino, O. J.; Mpondo, E. M.; Ntie-Kang, F.;* Ndom, J. C.; Bolzani, V. S. ; Wessjohann, L. Protease-inhibiting, molecular modelling and antimicrobial activities of extracts and constituents of Helichrysum foetidum and Helichrysum mechowianum (Compositae). Chemistry Central Journal, 2015, 9, 32.
  61. Simoben, C. V.; Ibezim, A.; Ntie-Kang, F.;* Nwodo, J. N.; Lifongo, L. L. Exploring cancer therapeutics with natural products from African medicinal plants, part I: xanthones, quinones, steroids, coumarins, phenolics and other classes of compounds. Anti-Cancer Agents in Medicinal Chemistry, 2015, 15, 1092-1111.
  62. Yong, J. N.;† Ntie-Kang, F.*†The chemistry and biological activities of natural products from Northern African plant families: From Ebenaceae to Solanaceae. RSC Advances, 2015, 5, 26580-26595.
  63. Tietjen, I.; Ntie-Kang, F.; Mwimanzi, P.; Onguéné, P. A.; Scull, M. A.; Idowu, T. O.; Ogundaini, A. O.; Mbaze, L. M.; Abegaz, B. M.; Rice, C. M.; Andrae-Marobela, K.; Brockman, M. A.; Brumme, Z. L.; Fedida, D. Screening of the pan-African natural product library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors. PLoS ONE, 2015, 10, e0121099.
  64. Metuge, J. A.;†Ntie-Kang, F.;*†Ngwa, V. F.; Babiaka, S. B.; Samje, M.; Cho-Ngwa F. Molecular modelling of plant metabolites with anti-Onchocerca activity. Medicinal Chemistry Research, 2015, 24, 2127-2141.
  65. Ntie-Kang, F.;*†Yong, J. N.† The chemistry and biological activities of natural products from Northern African plant families: From Aloaceae to Cupresaceae. RSC Advances, 2014, 4, 61975-61991.
  66. Ntie-Kang, F.;*†Nwodo, J. N.;† Ibezim, A.; Simoben, C. V.; Karaman, B.; Ngwa, V. F.; Sippl, W.; Adikwu, M. U.; Mbaze, L. M. Molecular modeling of potential anticancer agents from African medicinal plants. Journal of Chemical Information and Modeling, 2014, 54, 2433-2450.
  67. Simoben, C. V.;†Ntie-Kang, F.;*†Lifongo, L. L.; Babiaka, S. B.; Sippl, W.; Mbaze, L. M. The uniqueness and therapeutic value of natural products from West African medicinal plants, part III: Least abundant compound classes. RSC Advances, 2014, 4, 40095-40110.
  68. Ntie-Kang, F.;* Lifongo, L. L.; Simoben, C. V.; Babiaka, S. B.; Sippl, W.; Mbaze, L. M. The uniqueness and therapeutic value of natural products from West African medicinal plants, part II: Terpenoids, geographical distribution, drug discovery. RSC Advances, 2014, 4, 35348-35370.
  69. Onguéné, P. A;†Ntie-Kang, F.;*†Mbah, J. A.; Lifongo, L. L.; Ndom, J. C.; Sippl, W.; Mbaze, L. M. The potential of anti-malarial compounds derived from African medicinal plants, part III: An in silico evaluation of drug metabolism and pharmacokinetics profiling. Organic and Medicinal Chemistry Letters, 2014, 4, 6.
  70. Ntie-Kang, F.;* Yong, J. N.; Owono, L. C. O.; Sippl, W.; Megnassan, E. Perspectives on tuberculosis pathogenesis and discovery of anti-tubercular drugs. Current Medicinal Chemistry, 2014, 21, 3466-3477.
  71. Metuge, J. A.; Babiaka, S. B.; Mbah, J. A.; Ntie-Kang, F.; Ayimele G.A.; Cho-Ngwa F. Anti-Onchocerca compounds from Cyperus articulatus: isolation, in vitro activity and in silico ‘drug-likeness’. Natural Products and Bioprospecting, 2014, 4, 243-249.
  72. Ntie-Kang, F.;* Lifongo, L. L.; Simoben, C. V.; Babiaka, S. B.; Sippl, W.; Mbaze, L. M. The uniqueness and therapeutic value of natural products from West African medicinal plants, part I: uniqueness and chemotaxonomy. RSC Advances, 2014, 4, 28728-28755.
  73. Yong, J. N.;†Ntie-Kang, F.*†Potential natural antimycobacterial metabolites from some sub-Saharan medicinal plants. Anti-Infective Agents, 2014, 12, 178-190.
  74. Ngo Hanna, J.; Ntie-Kang, F.; Kaiser, M.; Brun, R.; Efange, S. M. N. 1-Aryl-1,2,3,4-tetrahydroisoquinolines as potential antimalarials: synthesis, in vitro antiplasmodial activity and in silico pharmacokinetics evaluation. RSC Advances, 2014, 4, 22856-22865.
  75. Ntie-Kang, F.;*†Onguéné, P. A.;† Lifongo, L. L.; Ndom, J. C.; Sippl, W.; Mbaze, L. M. The potential of anti-malarial compounds derived from African medicinal plants, part II: A pharmacological evaluation of non-alkaloids and non-terpenoids. Malaria Journal, 2014, 13, 81.
  76. Lifongo, L. L.; Simoben, C. V.; Ntie-Kang, F.;* Babiaka, S. B.; Judson, P. N. A bioactivity versus ethnobotanical survey of medicinal plants from Nigeria, West Africa. Natural Products and Bioprospecting, 2014, 4, 1-19.
  77. Ntie-Kang, F.;†Onguéné, P. A.;† Fotso, G. W.; Andrae-Marobela, K.; Bezabih, M.; Ndom, J. C.; Ngadjui, B. T.; Ogundaini, A. O.; Abegaz, B. M.; Mbaze, L. M. Virtualizing the p-ANAPL compound library: A step towards drug discovery from African medicinal plants. PLoS ONE, 2014, 9, e90655.
  78. Zofou, D.; Nyasa, R. B.; Nsagha, D. S.; Ntie-Kang, F.; Meriki, H. D.; Assob, J. C. N.; Kuete, V. Control of malaria and other vector-borne protozoan diseases in the tropics: Enduring challenges, despite considerable progress and achievements. Infectious Diseases of Poverty, 2014, 3, 1.
  79. Ntie-Kang, F.;* Kannan, S.; Wichapong, K.; Owono, L. C. O.; Sippl, W.; Megnassan, E. Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: Docking and MM-GB(PB)SA analysis. Molecular BioSystems, 2014, 10, 223-239.
  80. Ntie-Kang, F.;* Lifongo, L. L.; Judson, P. N.; Sippl, W.; Efange, S. M. N. How “drug-like” are naturally occurring anticancer compounds? Journal of Molecular Modeling, 2014, 20, 2069.
  81. Ntie-Kang, F.;* Onguéné, P. A.; Scharfe, M.; Mbaze, L. M.; Owono, L. C. O.; Megnassan, E.; Sippl, W.; Efange, S. M. N. ConMedNP: A natural product library from Central African medicinal plants for drug discovery. RSC Advances, 2014, 4, 409-419. 
  82. Onguéné, P. A.;†Ntie-Kang, F.;*†Lifongo, L. L.; J. C. Ndom, Sippl, W.; Mbaze, L. M. The potential of anti-malarial compounds derived from African medicinal plants, part I: A pharmacological evaluation of alkaloids and terpenoids. Malaria Journal, 2013, 12, 449.
  83. Zofou, D.; Tene, M.; Ntie-Kang, F.; Tematio, E. L.; Ngemenya, M. N.; Tane, P.; Tatanji, V. P. K. Antimalarial hits from Dacryodes edulis (Burseraceae)-Part I: Isolation, in vitro activity, in silico “drug-likeness” and Pharmacokinetic profiles. PLoS ONE, 2013, 8, e79544.
  84. Ntie-Kang, F.;* Zofou, D.; Babiaka, S. B.; Meudom, R.; Scharfe, M.; Lifongo, L. L.; Mbah, J. A.; Mbaze, L. M.; Sippl, W.; Efange, S. M. N. AfroDb: A select highly potent and diverse natural product library from African medicinal plants. PLoS ONE, 2013, 8, e78085.
  85. Ntie-Kang, F.* An in silico evaluation of the ADMET profile of the StreptomeDB database. SpringerPlus, 2013, 2, 353.
  86. Ntie-Kang, F.;* Mbah, J. A.; Lifongo, L. L.; Owono, L. C. O.; Megnassan, E.; Mbaze, L. M.; Judson P. N.; Sippl, W.; Efange, S. M. N. Assessing the pharmacokinetic profile of the CamMedNP natural products database: An in silico approach. Organic and Medicinal Chemistry Letters, 2013, 3, 10.
  87. Ntie-Kang, F.;* Lifongo, L. L.; Mbah, J. A.; Owono, L. C. O.; Megnassan, E.; Mbaze, L. M.; Judson, P. N.; Sippl, W.; Efange, S. M. N. In silico drug metabolism and pharmacokinetic profiles of natural products from medicinal plants in the Congo basin. In Silico Pharmacology, 2013, 1, 12.
  88. Ntie-Kang, F.;* Lifongo, L. L.; Mbaze, L. M.; Ekwelle, N.; Owono, L. C. O.; Megnassan, E.; Judson, P. N.; Sippl, W.; Efange, S. M. N. Cameroonian medicinal plants: a bioactivity versus ethnobotanical survey and chemotaxonomic classification. BMC Complementary and Alternative Medicine, 2013, 13, 147.
  89. Zofou, D.;†Ntie-Kang, F.;*†Sippl, W.; Efange, S. M. N. Bioactive natural products derived from the Central African flora against neglected tropical diseases and HIV. Natural Product Reports, 2013, 30, 1098 - 1120.
  90. Ntie-Kang, F.;* Mbah, J. A.; Mbaze, L. M.; Lifongo, L. L.; Scharfe M.; Ngo Hanna, J.; Cho-Ngwa, F.; Onguéné, P. A.; Owono, L. C. O.; Megnassan, E.; Sippl, W.; Efange, S. M. N. CamMedNP: Building the Cameroonian 3D structural natural products database for virtual screening. BMC Complementary and Alternative Medicine, 2013, 13, 88.

 

Book chapters

 

  1. Simoben, C. V.; Ntie-Kang, F.*  African medicinal plants: An untapped reservoir of potential anticancer agents. In  Cancer Preventive and Therapeutic Compounds: Gift from Mother Nature. Prasad, S.; Tyagi, A. K. (Editors).  Bentham Science Publishers: 2017, 87-104.
  2. Ntie-Kang, F.* CamMedNP: Building the Cameroonian 3D Structural Natural Products Database for Virtual Screening. In Progress in Computer-Aided Drug Design. Academic Archives; ISBN: 978-1-61896-169-3, 2017, pp. xx-yy.
  3. Moumbock, A. F. A.; Simoben, C. V.;  Wessjohann, L.; Sippl, W.; Günther, S.; Ntie-Kang, F.* Computational studies and biosynthesis of natural products with promising anticancer properties. In Phytochemistry - Natural Products and Cancer. Badria, F. A. (Editor). InTech: ISBN 978-953-51-5277-4, 2017, pp. 257-285.
  4. Najjar, A.;  Ntie-Kang, F.;* Sippl, W. Application of Computer Modeling to Drug Discovery: Case Study of PRK1 Kinase Inhibitors as Potential Drugs in Prostate Cancer Treatment. In Unique Aspects of Anti-cancer Drug Development. Latosińska, J.; Latosińska, M. (Editors); InTech: ISBN 978-953-51-5240-8, 2017, pp. 17-47.

 

Publications awaiting decision

 

  1. Ntie-Kang, F.* Three fundamental steps towards framing a research topic or title of a publication.  Chemical Information Science (under revision).
  2. Bekono, B. D.; Esmel, A.; Dali, B.;   Ntie-Kang, F.;* Keita, M.; Owono, L. C. O.; Megnassan, E.; Frecer, V.; Miertus, S.   Computer-aided design of peptidomimetics inhibiting falcipain-3, QSAR and pharmacophore models. Chemical Data Collections, submitted.

 

Molecular modeling expert (Computational chemistry, computational biology, computational physics)